Parkinson’s Disease Causes, Symptoms, and Treatment Parkinson’s disease (PD) is one of the fastest-growing neurological ...
An MRI-based AI tool shows high accuracy in differentiating Parkinsonian syndromes in a large prospective study. Learn more.
ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...
Cross-trial analysis supports plasma pTau as a potential early predictor of clinical benefit, reinforcing the biomarker-driven design of ProMIS’ ...
Chennai: A new AI-enabled deep brain stimulation (DBS) device, one that can read brain signals and adjust itself, will be ...
Rare diseases reveal that our sense of identity rests on fragile biological infrastructure, much of it operating outside conscious awareness. Movement, balance, motivation, emotional tone—these feel ...
ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced ...
This valuable work provides new insights into the role of lysine acetylation of alpha-synuclein, the protein involved in Parkinson's Disease. The evidence is mostly solid, but the claims around the ...
In an exclusive interview, Alterity Therapeutics’ ( ATHE) CEO David Stamler met with The Fly to discuss the company, the biotech industry, ongoing trials, upcoming milestones and much more. Published ...
Hyperbaric Oxygen Therapy (HBOT) is emerging as a science-backed tool to boost brain performance, reverse decline, and ...
Dementia is a highly prevalent condition, affecting 57 million people worldwide, with nearly 10 million new cases each year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback